Home LiteratureArticle Details
PMID: 16287892 Published · ppublish English Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Disparities and survival among breast cancer patients.

Journal of the National Cancer Institute. Monographs ·No. 35 ·2005-00-00 ·Pages 88-95

Field TS, Buist DS, Doubeni C, Enger S, Fouayzi H, Hart G, Korner EJ, Lamerato L, Bachman DJ, Ellis J, Herrinton L, Hornbrook MC, Krajenta R, Liu L, Yao J

Abstract

Although rates of survival for women with breast cancer have improved, the survival disparity between African American and white women in the United States has increased. To determine whether this survival disparity persists in an insured population with access to medical care. In this retrospective cohort study, we extracted data from the tumor registries of six nonprofit, integrated health care delivery systems affiliated with the Cancer Research Network and assessed the survival of African American (n = 2276) and white (n = 18 879) female enrollees who were diagnosed with invasive breast cancer from January 1, 1993, through December 31, 1998. Cox proportional hazards regression was used to estimate the death rate among African American women relative to that of white women after adjustment for potential explanatory factors including stage at diagnosis, tumor characteristics, and treatment. Five-year survival was lower for African American women (73.8%) than for white women (81.6%). African American women were less likely to have tumor characteristics with good prognosis. Controlling for age at diagnosis, stage, grade, tumor size, and estrogen and progesterone receptor status, the adjusted hazard rate ratio for African American women was 1.34 (95% confidence interval = 1.22 to 1.46). Similar risks were found among women ages 20-49 and 50 and older. Controlling for treatment slightly lowered the hazard rate ratio to 1.31 (95% confidence interval = 1.20 to 1.43). Among women with invasive breast cancer, being insured and having access to medical care does not eliminate the survival disparity for African American women.

MeSH Terms
Adult Aged Aged, 80 and over Blacks Breast Neoplasms/mortality,therapy Cohort Studies Female Health Services Accessibility Humans Middle Aged Neoplasm Invasiveness/diagnosis Prognosis Receptors, Estrogen/metabolism Receptors, Progesterone/metabolism Registries/statistics & numerical data Retrospective Studies SEER Program Survival Rate United States/epidemiology Whites
Chemicals
Receptors, Estrogen Receptors, Progesterone
Authors & Affiliations
15 authors, click to expand affiliations / ORCID
Field Terry S
Meyers Primary Care Institute, University of Massachusetts Medical School, Fallon Foundation, and Fallon Community Health Plan, 630 Plantation St., Worcester, MA 01605, USA. tfield@meyersprimary.org
Buist Diana S M
Doubeni Chyke
Enger Shelley
Fouayzi Hassan
Hart Gene
Korner Eli J
Lamerato Lois
Bachman Donald J
Ellis Jennifer
Herrinton Lisa
Hornbrook Mark C
Krajenta Rick
Liu Liyan
Yao Janice
Article Info
Journal
Journal of the National Cancer Institute. Monographs
Abbr.
J Natl Cancer Inst Monogr
ISSN
1052-6773
Published
2005-00-00
Pages
88-95
Language
English
Region
United States
NLM ID
9011255
Subset
IM
Grants
NCI NIH HHS · CA79689 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com